INIS
risks
100%
psychoses
88%
control
53%
genes
51%
patients
46%
genetics
44%
symptoms
43%
levels
37%
dna
37%
interactions
35%
methylation
32%
populations
28%
mice
27%
nervous system diseases
27%
brain
25%
environment
25%
data
25%
trauma
20%
people
18%
reviews
18%
humans
17%
comparative evaluations
17%
liabilities
15%
hippocampus
13%
spectra
12%
receptors
12%
aging
11%
proteins
11%
regulations
11%
animals
11%
variations
11%
blood
11%
adults
11%
phenotype
10%
assessments
10%
sex
9%
vulnerability
9%
neurons
9%
performance
9%
dimensions
9%
sampling
8%
diseases
8%
mental disorders
8%
dynamics
8%
males
8%
adolescents
8%
therapy
7%
sensitivity
7%
values
7%
methyl transferases
7%
Keyphrases
Schizophrenia
50%
Psychosis
41%
Posttraumatic Stress Disorder
29%
Clinical High Risk for Psychosis (CHR-P)
28%
First-episode Psychosis
26%
Psychotic Disorders
25%
Polygenic Risk Score
21%
Psychotic Experiences
17%
Gene-environment Interaction
17%
DNA Methylation (DNAm)
17%
Cannabis Use
17%
Psychopathology
16%
Alzheimer's Disease
15%
Healthy Controls
13%
Clinical High Risk
12%
Childhood Adversity
12%
Exposome
12%
Meta-analysis
11%
Epigenetics
10%
Hippocampus
10%
Clinical Outcomes
9%
Cannabis
9%
Mental Health
9%
Daily Life
9%
Schizophrenia Spectrum Disorders
8%
Genetic Liability
8%
Experience Sampling
8%
Polygenic Risk
8%
Childhood Trauma
8%
Epigenetic Mechanisms
8%
Epigenetic Modification
7%
Electroconvulsive Therapy
7%
Psychotic Symptoms
7%
Mental Disorders
7%
Age-related
6%
Methylation
6%
Genetic Risk
6%
5-hydroxymethylcytosine (5hmC)
6%
Caloric Restriction
6%
Posttraumatic Stress
6%
Confidence Interval
6%
Risk Factors
6%
Depressive Symptoms
6%
Cognitive Impairment
6%
Major Depressive Disorder
5%
Sibling Controls
5%
Patients with Schizophrenia
5%
Kynurenine
5%
Genome-wide Association Study
5%
Environmental Factors
5%